| Execution period | FY 2026-27 |
|---|
NSE filing, NSE: RCDL. Summary written from the filing by ALFA Finder's alert engine.
Rajgor Castor Derivatives Ltd: key numbers
- Share price
- ₹17.00
- Market cap
- ₹81.31 Cr
- Revenue (annual)
- ₹872.2 Cr
- Net profit (annual)
- ₹12.63 Cr
- P/E (TTM)
- 6.4×Sector 38.3×
- Promoter holding
- 55.18%
- FII holding
- 2.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rajgor Castor Derivatives Ltd
All →Rajgor Castor Derivatives Other Announcement
Rajgor Castor Derivatives files its integrated governance report for the half year ended September 30, 2026. The routine compliance filing contains no transaction or financial figures.
Rajgor Castor Derivatives Capital Structure Change
Rajgor Castor Derivatives Limited has allotted 23,913,000 equity shares pursuant to its rights issue. The company's paid-up share capital has increased following this allotment.
Rajgor Castor Derivatives Capital Structure Change
Rajgor Castor Derivatives Limited allotted 2.39 crore equity shares on a rights basis at Rs. 10 per share, raising approximately Rs. 23.91 crore.
- Value
- ₹23.91 Cr
Rajgor Castor Derivatives Capacity Expansion: ₹61.5 Cr Investment
Rajgor Castor Derivatives Ltd is expanding manufacturing capacity by 348 MT/day with a ₹61.50 Crore investment, funded by term loans and internal accruals.
- Value
- ₹61.50 Cr
- Execution
- Approx 10 months
- manufacturing capacity
- 348.0 MT per day
Rajgor Castor Derivatives Price Movement Clarification
Rajgor Castor Derivatives Limited clarified to the NSE that the recent movement in its share price is market-driven and not due to undisclosed material information.
Rajgor Castor Derivatives Annual General Meeting
RCDL filed proceedings of its 8th AGM held September 18, 2026, adopting FY26 financials and approving a ₹0.10 per share dividend among other resolutions.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.